Anzeige
Mehr »
Dienstag, 11.11.2025 - Börsentäglich über 12.000 News
Nuklear-Deal startet: 80-Mrd.-Dollar-Atomoffensive der USA
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PH0N | ISIN: CA2524423068 | Ticker-Symbol: 4D4A
Frankfurt
11.11.25 | 08:06
0,179 Euro
+4,07 % +0,007
1-Jahres-Chart
DIAGNOS INC Chart 1 Jahr
5-Tage-Chart
DIAGNOS INC 5-Tage-Chart

Aktuelle News zur DIAGNOS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoDIAGNOS Inc.: DIAGNOS Announces $2.0 Million Brokered Private Placement Led by Centurion One Capital2
DIAGNOS Aktie jetzt für 0€ handeln
30.10.Diagnos Inc (3): Diagnos appoints Couillard as chairman5
30.10.DIAGNOS Inc.: DIAGNOS Strengthens Governance and Leadership with the Appointment of Philippe Couillard as Chairman of the Board of Directors120BROSSARD, Quebec, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. ("DIAGNOS" or the "Corporation") (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health issues...
► Artikel lesen
27.10.Diagnos Inc (3): Diagnos appoints Charlebois to advisory board1
27.10.DIAGNOS Inc.: DIAGNOS Welcomes Dr. Pierre-Luc Charlebois to its Advisory Board1
23.10.Diagnos Inc (3): Diagnos to extend 1.12 million warrants to 20262
22.10.DIAGNOS Inc.: DIAGNOS to Extend Exercise Period of Stock Warrants Expiring on November 9, 20251
15.10.Centurion One Capital Corp.: DIAGNOS to Present at the Centurion One Capital 3rd Annual Bahamas Summit296Brossard, Quebec--(Newsfile Corp. - October 15, 2025) - Diagnos Inc. (TSXV: ADK) (OTCQB: DGNOF) (FSE: 4D4A) ("DIAGNOS" or the "Corporation"), a pioneer in early detection of critical health issues...
► Artikel lesen
09.10.Diagnos Inc (3): Diagnos passes annual MDSAP audit1
26.09.Diagnos Inc (3): Diagnos shareholders elect four directors at AGM4
25.09.DIAGNOS Inc.: DIAGNOS Announces Voting Results of Meeting of Shareholders69BROSSARD, Quebec, Sept. 25, 2025 (GLOBE NEWSWIRE) -- DIAGNOS Inc. ("DIAGNOS" or the "Corporation") (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health issues...
► Artikel lesen
11.09.Diagnos Inc (3): Diagnos $100,000 debenture private placement3
06.09.Diagnos Inc (3): Diagnos closes $100,000 private placement1
05.09.DIAGNOS Inc.: DIAGNOS Announces Closing of Private Placement1
03.09.DIAGNOS Inc.: DIAGNOS Announces Private Placement1
20.08.Diagnos Inc (3): Diagnos 2,064,286 warrants extended1
15.08.DIAGNOS Inc.: DIAGNOS to Extend Stock Warrants Exercise Period2
14.08.Diagnos Inc (3): Diagnos to extend 1.41 million warrants1
13.08.DIAGNOS Inc.: DIAGNOS Announces Extension of Stock Warrants Exercise Period1
17.07.Diagnos Inc (3): Diagnos files FDA presub for AI eye screening tool1
Weiter >>
36 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1